Prospera Financial Services Inc Evolus, Inc. Transaction History

Prospera Financial Services Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	BUY	$7.76 - $13.72 $1,505 - $2,661	194 Added 1.65%	11,976 $96,000
Q2 2022 Aug 08, 2022	BUY	$10.22 - $13.94 $33,623 - $45,862	3,290 Added 38.74%	11,782 $137,000
Q1 2022 May 04, 2022	BUY	$5.22 - $11.78 $44,328 - $100,035	8,492 New	8,492 $95,000
Q4 2020 Feb 12, 2021	SELL	$2.92 - $4.84 $613 - $1,016	-210 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$3.03 - $5.48 $636 - $1,150	210 New	210 $1,000

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $608M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

Stay updated on Prospera Financial Services Inc with notifications on news.